시장보고서
상품코드
1091409

뼈 및 관절용 재생의료 시장

Regenerative Medicines: Bone and Joint Applications

발행일: | 리서치사: BCC Research | 페이지 정보: 영문 105 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 뼈 및 관절용 재생의료 시장 규모는 2022년에 94억 달러에 달했습니다.

이 시장은 2022-2027년의 예측 기간 중 11.6%의 CAGR로 확대하며, 2027년에는 164억 달러에 달할 것으로 예측되고 있습니다.

세계의 뼈 및 관절용 재생의료 시장에 대해 조사했으며, 시장의 개요와 기술별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 정리와 하이라이트

제3장 시장과 기술 배경

  • 재생의료의 개요
  • 재생의료의 구조
  • 재생의료에 대한 주요 어프로치
  • 세포와 조직
  • 인체조직공학
  • 배아줄기세포

제4장 COVID-19의 영향

제5장 시장 역학

  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
  • 경쟁 구도

제6장 시장 내역, 기술별

  • 세계 시장, 기술별
  • 생체 재료
  • 재생을 위한 생체 재료
  • 줄기세포 치료
  • 인체조직공학

제7장 시장 내역, 용도별

  • 세계 시장, 용도별
  • 동종골
  • 자가골
  • 골이식 대체물
  • 골관절 질환
  • 기타

제8장 시장 내역, 지역별

  • 세계 시장, 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제9장 기업 개요

  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAXTER INTERNATIONAL INC.
  • BIOVENTUS
  • CONMED CORP.
  • DEPUY SYNTHES PRODUCTS INC.(PART OF JOHNSON & JOHNSON)
  • MEDTRONIC PLC
  • SEIKAGAKU CORP.
  • SMITH & NEPHEW PLC
  • STRYKER CORP.
  • ZIMMER BIOMET HOLDINGS INC.

제10장 부록 : 두자어 리스트

KSA 22.06.29

Highlights:

The global regenerative medicine for bone and joint applications market should reach $16.4 billion by 2027 from $9.4 billion in 2022 at a compound annual growth rate (CAGR) of 11.6% for the forecast period of 2022 to 2027.

The biomaterials technology segment of the global regenerative medicine for bone and joint applications market is expected to grow from $5.9 billion in 2022 to $10.2 billion in 2027 at a CAGR of 11.5% for the forecast period of 2022 to 2027.

The tissue engineering technology segment of the global regenerative medicine for bone and joint applications market is expected to grow from $2.3 billion in 2022 to $4.1 billion in 2027 at a CAGR of 12.0% for the forecast period of 2022 to 2027.

Report Scope:

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases and others.

The report provides information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

  • 51 tables
  • An overview of the global market for regenerative medicines for bone and joint applications
  • Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Characterization and quantification of market potential for regenerative medicines by technology, application, and region
  • Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
  • Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
  • Information on major drivers and regional dynamics of the market and current trends within the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
  • Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.

Table of Contents

Chapter 1 Introduction

  • Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in This Update?
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Regenerative Medicine
  • How Regenerative Medicine Works
  • Principal Approaches to Regenerative Medicine
  • Cells and Tissues
  • Tissue Engineering
  • Importance of Scaffolding in Tissue Engineering
  • Plastic Scaffolding
  • Blood Vessel Scaffolding
  • Center for Integration of Medicine and Innovative Technology (CIMIT)
  • Embryonic Stem Cells

Chapter 4 Impact of COVID-19

  • Overview
  • Impact of COVID-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
  • Direct Impact on Clinical Trials in Cell and Gene Therapy

Chapter 5 Market Dynamics

  • Market Drivers
  • Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
  • Increasing Product Approvals and Launches
  • R&D for Stem and Gene Therapies
  • Market Restraints
  • Stringent Government Regulatory Settings in R&D
  • Market Opportunities
  • Growing Pipeline for Regenerative Medicines
  • Competitive Landscape

Chapter 6 Market Breakdown by Technology

  • Global Market by Technology
  • Biomaterials
  • Biomaterials for Regeneration
  • Market Size and Forecast
  • Stem Cell Therapy
  • Market Size and Forecast
  • Tissue Engineering
  • Market Size and Forecast

Chapter 7 Market Breakdown by Application

  • Global Market by Application
  • Allogeneic Bones
  • Market Size and Forecast
  • Autogenic Bones
  • Market Size and Forecast
  • Bone Graft Substitutes
  • Market Size and Forecast
  • Osteoarticular Diseases
  • Market Size and Forecast
  • Other Diseases
  • Market Size and Forecast

Chapter 8 Market Breakdown by Region

  • Global Market by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 9 Company Profiles

  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAXTER INTERNATIONAL INC.
  • BIOVENTUS
  • CONMED CORP.
  • DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
  • MEDTRONIC PLC
  • SEIKAGAKU CORP.
  • SMITH & NEPHEW PLC
  • STRYKER CORP.
  • ZIMMER BIOMET HOLDINGS INC.

Chapter 10 Appendix: List of Acronyms

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제